These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35355076)

  • 1. Neurological manifestations of Kyasanur Forest disease: a retrospective cohort study from South India.
    Gupta N; Nallapati VT; Chunduru K; Vithivattical ARJ; Kadavigere R; Saravu K
    Trans R Soc Trop Med Hyg; 2022 Oct; 116(10):944-948. PubMed ID: 35355076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory profile of patients with Kyasanur forest disease: A single-centre study of 192 patients from Karnataka, India.
    Gupta N; Chunduru K; Safeer K M; Saravu K
    J Clin Virol; 2021 Feb; 135():104735. PubMed ID: 33493988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kyasanur Forest Disease (KFD): Rare Disease of Zoonotic Origin.
    Muraleedharan M
    J Nepal Health Res Counc; 2016 Sep; 14(34):214-218. PubMed ID: 28327690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Laboratory Diagnostic Features of Kyasanur Forest Disease: A Study From Wayanad, South India.
    Gladson V; Moosan H; Mathew S; P D
    Cureus; 2021 Dec; 13(12):e20194. PubMed ID: 35004016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in clinical presentation between the first and second phases of Kyasanur Forest disease: an experience from a teaching hospital in South India.
    Gupta N; Varma M; Saravu K
    Infez Med; 2020 Nov; 28(4):597-602. PubMed ID: 33257636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical & epidemiological significance of Kyasanur forest disease.
    Munivenkatappa A; Sahay RR; Yadav PD; Viswanathan R; Mourya DT
    Indian J Med Res; 2018 Aug; 148(2):145-150. PubMed ID: 30381537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kyasanur forest disease: an epidemiological view in India.
    Pattnaik P
    Rev Med Virol; 2006; 16(3):151-65. PubMed ID: 16710839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and spatial distribution of Ixodid tick populations in the forest fringes of Western Ghats reported with human cases of Kyasanur forest disease and monkey deaths in South India.
    Sadanandane C; Gokhale MD; Elango A; Yadav P; Mourya DT; Jambulingam P
    Exp Appl Acarol; 2018 May; 75(1):135-142. PubMed ID: 29594846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kyasanur forest disease: a state-of-the-art review.
    Gupta N; Wilson W; Neumayr A; Saravu K
    QJM; 2022 Jun; 115(6):351-358. PubMed ID: 33196834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An outbreak of Kyasanur forest disease in the Wayanad and Malappuram districts of Kerala, India.
    Sadanandane C; Elango A; Marja N; Sasidharan PV; Raju KHK; Jambulingam P
    Ticks Tick Borne Dis; 2017 Jan; 8(1):25-30. PubMed ID: 27692988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case Series on the Spectrum of Complications Observed in Kyasanur Forest Disease.
    Gladson V; Mathew S; J B; Aayilliath K A; Kumar P J; R S R
    Cureus; 2024 May; 16(5):e59971. PubMed ID: 38854314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kyasanur Forest Disease Prevalence in Western Ghats Proven and Confirmed by Recent Outbreak in Maharashtra, India, 2016.
    Gurav YK; Yadav PD; Gokhale MD; Chiplunkar TR; Vishwanathan R; Patil DY; Jain R; Shete AM; Patil SL; Sarang GD; Sapkal GN; Andhare MD; Sale YR; Awate PS; Mourya DT
    Vector Borne Zoonotic Dis; 2018 Mar; 18(3):164-172. PubMed ID: 29336707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the clinical manifestations and risk factors in people affected during the first Kyasanur Forest Disease outbreak in Goa, India: A mixed method study.
    Kuchelkar SP; Dias A; Gomes E; Dias L
    J Vector Borne Dis; 2024 Jan; 61(1):23-28. PubMed ID: 38648403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kyasanur Forest Disease in India: innovative options for intervention.
    Rajaiah P
    Hum Vaccin Immunother; 2019; 15(10):2243-2248. PubMed ID: 30945970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, epidemiological, and molecular investigation of Kyasanur forest disease from Karnataka state, India during 2018-2019.
    Munivenkatappa A; Yadav PD; Sahay RR; Sk K; Shete AM; Patil DY; Mohandas S; Jain R; Patil S; Sinha DP; Jayaswamy MM
    Infect Dis (Lond); 2024 Feb; 56(2):145-156. PubMed ID: 37966909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of human infection with Kyasanur Forest Disease Virus.
    Devadiga S; Arunkumar G
    J Infect; 2022 Aug; 85(2):161-166. PubMed ID: 35609707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forest loss shapes the landscape suitability of Kyasanur Forest disease in the biodiversity hotspots of the Western Ghats, India.
    Walsh MG; Mor SM; Maity H; Hossain S
    Int J Epidemiol; 2019 Dec; 48(6):1804-1814. PubMed ID: 31740967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coverage and effectiveness of Kyasanur forest disease (KFD) vaccine in Karnataka, South India, 2005-10.
    Kasabi GS; Murhekar MV; Sandhya VK; Raghunandan R; Kiran SK; Channabasappa GH; Mehendale SM
    PLoS Negl Trop Dis; 2013; 7(1):e2025. PubMed ID: 23359421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study of 100 cases of Kyasanur Forest disease with clinicopathological correlation.
    Adhikari Prabha MR; Prabhu MG; Raghuveer CV; Bai M; Mala MA
    Indian J Med Sci; 1993 May; 47(5):124-30. PubMed ID: 8225455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a clinical scoring system to make a presumptive diagnosis of Kyasanur Forest Disease: a case-control study from South India.
    Gupta N; Boodman C; Saravu K
    Infez Med; 2024; 32(1):61-68. PubMed ID: 38456026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.